Quantcast

Latest Biologic Stories

2014-06-23 08:27:48

BEIJING, June 23, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that on June 18, 2014, the Ministry of Finance of China and the State Administration of Taxation of China jointly published a notice to reduce and unify the value added tax ("VAT") rate on sales of a wide range of products in China, which will take effect on July 1, 2014. Pursuant to the...

2014-06-19 23:06:03

Senior Executives from Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, are to present at the forthcoming BIO International conference, which takes place from June 23rd to 26th at the San Diego Convention Center, San Diego, CA. Somerset, N.J. (PRWEB) June 19, 2014 Senior Executives from Catalent Pharma Solutions, the leading global provider of advanced delivery technologies...

2014-06-19 23:01:46

Protecting consumers requires the ability to track products. Washington, DC (PRWEB) June 19, 2014 “The promise of personalized medicine will only be achieved when adequate information is available to clinicians to tailor care to the individual and ensure the best health outcomes for all,” said Jane L. Delgado, President and CEO of the National Alliance for Hispanic Health (the Alliance). Citing the “historic and continuing underrepresentation of minorities in clinical trials,” the...

2014-06-18 16:27:02

BETHESDA, Md., June 18, 2014 /PRNewswire-USNewswire/ -- The Parenteral Drug Association has confirmed the participation of 27 officials from the U.S. FDA, including CDER Director Janet Woodcock, MD, as speakers at the 2014 PDA/FDA Joint Regulatory Conference. Besides the Office for Drug Evaluation and Research (CDER), the FDA Centers for Biologics Evaluation and Research (CBER), Devices and Radiological Health (CDRH), and Veterinary Medicine (CVM), along with the Office of Regulatory...

2014-06-18 16:26:53

KANSAS CITY, Kan., June 18, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion animals, today announced that it is currently enrolling patients in two nationwide clinical trials to evaluate its monoclonal antibody for canine T-cell lymphoma, AT-005, which is conditionally licensed by the USDA to aid in the treatment of...

2014-06-18 04:21:25

Change in regulatory frameworks and standards are essential to expedite approval and release of innovative products LONDON, June 18, 2014 /PRNewswire/ -- Regenerative medicine has the potential to transform healthcare all over the world and usher human health into a new era of wellness. Currently, the majority of treatments for chronic and fatal diseases is palliative or to delay disease progression; in contrast, regenerative medicine is uniquely capable of altering the underlying...

2014-06-17 08:28:44

SEATTLE, June 17, 2014 /PRNewswire/ -- CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, have entered into a Master Services Agreement for process validation activities and clinical manufacturing of another of MacroGenics'...

2014-06-16 23:04:46

GIA announces the release of a comprehensive global report on Growth Factors (Blood and Tissue) markets. Global market for Growth Factors (Blood and Tissue) is forecast to reach US$48 billion by 2020, driven by growing demand for effective, cost-efficient therapeutics, and increasing significance of growth factors in the treatment of chemotherapy-associated anemia and neutropenia. San Jose, California (PRWEB) June 16, 2014 Follow us on LinkedIn – Fuelled by the growing importance of...

2014-06-12 23:12:14

Surgeons at separate in-office clinics independently have found that just one application of PX50™ shows successful results in non-invasive treatments for patients with plantar fasciitis and osteoarthritis, after failed conservative management. Redondo Beach, CA (PRWEB) June 12, 2014 Skye OrthoBiologics, LLC is a regenerative and osteobiologic solutions Biotechnology Company engaged in the development and commercialization of novel human tissue-based amniotic and placental biologic...

2014-06-11 16:27:22

Phase 3 Program Underway to Further Assess Brodalumab as Potential Treatment for People Living With Psoriatic Arthritis THOUSAND OAKS, Calif. and LONDON, June 11, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced that results from a Phase 2 study evaluating brodalumab in 168 patients with psoriatic arthritis were published in The New England Journal of Medicine (NEJM). These data will also be presented at the 2014 European League Against Rheumatism (EULAR)...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'